Detecting those at high fracture risk
Deakin researchers have shown a weak link in the fracture risk tool FRAX.
What's new in Bipolar Disorder research?
On World Bipolar Day, IMPACT hosted a public seminar to outline the latest research.
Men express less satisfaction with their quality of life after suffering a fracture.
Heavy metal and the blues
IMPACT researchers find a connection between cadmium and depression.
Muscle or fat?
Young men are less healthy than we thought - research shows an alarming increase in obesity.
+61 4215 3320
IMPACT Strategic Research Centre (Barwon Health)
School of Medicine
PO Box 281
Geelong Victoria 3220
Biological psychiatry is at the forefront of understanding the underlying factors involved in psychiatric disorders. In the IMPACT SRC we focus on alternative targets to treat the symptoms of psychiatric disorders using a multitude of approaches ranging from basic science through to clinical trials. Our trials are designed to fill the gap that conventional therapies often leave between getting better and complete, functional recovery. We target alterations in oxidative biology, inflammation, neurogenesis and mitochondrial dysfunction, factors that are believed to be important in the pathology of many psychiatric illnesses.
The SRC currently has a register open to anyone who has a psychiatric disorder and would be interested in taking part in our studies. If you would like more information regarding the register please contact Dr Olivia Dean - (03) 4215 3300.
Additionally, we have several studies that are currently recruiting:
- Mino UD trial
This study is trialling minocycline as an add-on to usual treatment for depression. The study requires people to attend seven interviews over the course of 16-weeks. The study is currently recruiting and seeking both men and women aged 18 years or over to take part.
Contact: Dr Olivia Dean 03 4215 3300 or email@example.com.
- Mito NAC trial
This trial involves N-acetyl cysteine, known as NAC, in combination with other nutraceutical agents as a potential new treatment for bipolar disorder. We are seeking volunteers for the trial who are over 18 years of age and have a diagnosis of bipolar disorder. The study requires people to attend seven interviews over the course of 20-weeks.
Contact: Dr Alyna Turner 03 4215 3313 or email firstname.lastname@example.org
- YoDA-A trial
This trial involves rosuvastatin and aspirin as treatments for youth depression. Please note this study requires participants to be currently undergoing treatment at; Orygen Youth Health Clinical Program, Headspace Sunshine or Headspace Glenroy.
Deakin University CRICOS Provider Code: 00113B